Holdings of Pfizer Inc
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 14 in 2 countries
- Top ten
- 99.2 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ORIC Pharmaceuticals Inc | 4,780,401 | 57.7M $ | |
| 2 | Allogene Therapeutics Inc | 22,032,040 | 49.8M $ | |
| 3 | Arvinas Inc | 3,457,815 | 34.9M $ | |
| 4 | Celcuity Inc | 295,652 | 31.3M $ | |
| 5 | Pyxis Oncology Inc | 7,032,770 | 9.2M $ | |
| 6 | Caribou Biosciences Inc | 4,690,431 | 8.3M $ | |
| 7 | Spero Therapeutics Inc | 2,362,348 | 5.5M $ | |
| 8 | Cardiff Oncology Inc | 2,411,575 | 3.7M $ | |
| 9 | Zentalis Pharmaceuticals Inc | 953,834 | 2M $ | |
| 10 | NEXTCURE INC | 153,354 | 1.5M $ | |
| 11 | AGOMAB THERAPEUTICS SA | 75,000 | 813.8K $ | |
| 12 | Q32 Bio Inc | 101,618 | 736.7K $ | |
| 13 | BOLT BIOTHERAPEUTICS INC | 31,305 | 137.1K $ | |
| 14 | Ginkgo Bioworks Holdings Inc | 2,928 | 17.4K $ |
Sector breakdown
- Unattributed 100.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 99.6 %
- Belgium 0.4 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 13 | 204.9M $ | 99.60 % |
| 2 | Belgium | 1 | 813.8K $ | 0.40 % |
Cite this page
Titelia. "Holdings of Pfizer Inc". https://titelia.com/en/funds/US13F78003